Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 [(2S) tetrahydrofuran 2 yl] ethyl ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105669606B details a novel CDI-mediated route for high-optical-purity intermediates. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing without Grignard reagents.